Pfizer Confident In Lipitor Backup Plan, But Wall Street Seems On The Fence

Although Pfizer maintains it has a reasonably failsafe plan in place to weather the loss of exclusivity for its blockbuster cholesterol drug Lipitor and other products in coming, Wall Street appears less confident in the drug maker's ability to come out ahead